Volgen
Burak Ozgur
Burak Ozgur
PhD fellow, University of Copenhagen, Denmark
Geverifieerd e-mailadres voor sund.ku.dk
Titel
Geciteerd door
Geciteerd door
Jaar
Transendothelial electrical resistance measurement across the blood–brain barrier: a critical review of methods
JP Vigh, A Kincses, B Ozgür, FR Walter, AR Santa-Maria, S Valkai, ...
Micromachines 12 (6), 685, 2021
952021
Hypoxia increases expression of selected blood–brain barrier transporters GLUT-1, P-gp, SLC7A5 and TFRC, while maintaining barrier integrity, in brain capillary endothelial …
B Ozgür, HCC Helms, E Tornabene, B Brodin
Fluids and Barriers of the CNS 19 (1), 1, 2022
302022
Human induced pluripotent stem cells (BIONi010-C) generate tight cell monolayers with blood-brain barrier traits and functional expression of large neutral amino acid …
C Goldeman, M Andersen, A Al-Robai, T Buchholtz, N Svane, B Ozgür, ...
European Journal of Pharmaceutical Sciences 156, 105577, 2021
182021
Culture-induced changes in mRNA expression levels of efflux and SLC-transporters in brain endothelial cells
C Goldeman, B Ozgür, B Brodin
Fluids and Barriers of the CNS 17, 1-12, 2020
142020
Transendothelial electrical resistance measurement across the blood–brain barrier: a critical review of methods. Micromachines. 2021
JP Vigh, A Kincses, B Ozgür, FR Walter, AR Santa-Maria, S Valkai, ...
132022
Highly cationic cell-penetrating peptides affect the barrier integrity and facilitates mannitol permeation in a human stem cell-based blood-brain barrier model
P Frøslev, H Franzyk, B Ozgür, B Brodin, M Kristensen
European Journal of Pharmaceutical Sciences 168, 106054, 2022
132022
Characterization of the IPEC-J2 MDR1 (iP-gp) cell line as a tool for identification of P-gp substrates
B Ozgür, L Saaby, K Langthaler, B Brodin
European Journal of Pharmaceutical Sciences 112, 112-121, 2018
102018
The cell-penetrating peptide tat facilitates effective internalization of PSD-95 inhibitors into blood–brain barrier endothelial cells but less efficient permeation across the …
EL Al Humaidan, SL Pedersen, A Burkhart, CLM Rasmussen, T Moos, ...
Frontiers in Drug Delivery 2, 854703, 2022
92022
Screening novel CNS drug candidates for P-glycoprotein interactions using the cell line iP-gp: in vitro efflux ratios from iP-gp and MDCK-MDR1 monolayers compared to brain …
B Ozgür, L Saaby, C Janfelt, K Langthaler, E Eneberg, AM Jacobsen, ...
European Journal of Pharmaceutics and Biopharmaceutics 169, 211-219, 2021
82021
Characterization of an iPSC-based barrier model for blood-brain barrier investigations using the SBAD0201 stem cell line
B Ozgür, E Puris, A Brachner, A Appelt-Menzel, S Oerter, V Balzer, ...
Fluids and Barriers of the CNS 20 (1), 96, 2023
62023
Data demonstrating the challenges of determining the kinetic parameters of P-gp mediated transport of low-water soluble substrates
B Ozgür, L Saaby, K Langthaler, B Brodin
Data in brief 16, 655-659, 2018
62018
The putative proton-coupled organic cation antiporter is involved in uptake of triptans into human brain capillary endothelial cells
N Svane, ABV Pedersen, A Rodenberg, B Ozgür, L Saaby, C Bundgaard, ...
Fluids and Barriers of the CNS 21 (1), 39, 2024
42024
Subcellular trafficking and transcytosis efficacy of different receptor types for therapeutic antibody delivery at the blood‒brain barrier
MR Holst, NM de Wit, B Ozgür, A Brachner, K Hyldig, A Appelt-Menzel, ...
Fluids and Barriers of the CNS 20 (1), 82, 2023
42023
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–13